IRIX
IRIDEX Delivers Record-Breaking Q4 Performance with Strong Revenue Growth and Cost Optimization
IRIDEX, a leading provider of ophthalmic diagnostic imaging products, has announced its fourth quarter and full year results for 2025. The company's financial performance has exceeded expectations, marking a successful transformation and setting the stage for sustainable profitability. In a conference call held on March 26, 2026, Patrick